Primus In News
Indian CDMOs get a growth pill
28-01-2026
Nilaya Varma, Group CEO and Co-Founder, Primus Partners, shared his view that the free trade agreement would open access to Europe’s pharmaceutical and medical devices market, valued at around $572 billion, while strengthening India’s position as a global manufacturing hub.
Explore Related Insights
- Online games and self-publishing platforms: movie producers tap new avenues for fresh plotlines
- How this Pune-based startup is using drones to make confined-space industrial inspections safer
- New verification features may add to social media platforms' woes
- Iran War Battered Your Portfolio? These 10 Stocks May Offer Relief
